Can eliminating risk stratification improve medical residents' adherence to venous thromboembolism prophylaxis?
- PMID: 22030760
- DOI: 10.1097/ACM.0b013e318235c3f6
Can eliminating risk stratification improve medical residents' adherence to venous thromboembolism prophylaxis?
Abstract
Purpose: Hospital-acquired venous thromboembolism (VTE) is a common and preventable adverse event that most patients are at risk of developing during their hospital stay. VTE prophylactic anticoagulation (chemoprophylaxis) is the preferred pharmacological assignment for reducing risk of VTE, but it is underused in current practices involving risk stratification (RS) for VTE prevention. The purpose of this study was to determine whether a protocol that eliminates the RS step (non-RS protocol) is more likely to lead residents to evidence-based VTE assignment than the currently used RS protocol. The non-RS protocol follows a methodology that reduces complexity by assuming that the risk of VTE is present and uses contraindications to determine appropriate VTE assignment.
Method: In 2009, 41 medicine residents at the Nebraska Western Iowa Veterans Affairs clinic participated in an online comparison of two different protocols (RS and non-RS) for assigning chemoprophylaxis for VTE. Six validated, hypothetical patient scenarios were used to compare appropriate (evidence-based) VTE assignments for VTE and completion times for each protocol.
Results: Statistical analyses found that the non-RS protocol produced significantly faster (P < .001) scenario completion times and significantly more (P < .001) appropriate VTE assignments than the RS protocol for four of the six patient scenarios.
Conclusions: This study used a new, streamlined protocol (non-RS), which improved VTE assignment and the use of chemoprophylaxis and simplified the process when compared with the use of a traditional RS protocol.
Similar articles
-
Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.Arch Surg. 2012 Oct;147(10):901-7. doi: 10.1001/archsurg.2012.2024. Arch Surg. 2012. PMID: 23070407
-
A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.N Z Med J. 2010 Feb 19;123(1309):37-49. N Z Med J. 2010. PMID: 20186241
-
Clinical and economic outcomes with appropriate or partial prophylaxis.Thromb Res. 2010 Jun;125(6):513-7. doi: 10.1016/j.thromres.2009.10.018. Thromb Res. 2010. PMID: 19931121
-
Strategies for venous thromboembolism prophylaxis programs.Postgrad Med. 2011 Nov;123(6):91-101. doi: 10.3810/pgm.2011.11.2499. Postgrad Med. 2011. PMID: 22104458 Review.
-
Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.Cancer Treat Rev. 2009 Dec;35(8):754-64. doi: 10.1016/j.ctrv.2009.08.009. Epub 2009 Sep 16. Cancer Treat Rev. 2009. PMID: 19762155 Review.
Cited by
-
Venous Thromboembolism Prophylaxis in Acutely Ill Veterans With Respiratory Disease.Fed Pract. 2015 Apr;32(4):30-37. Fed Pract. 2015. PMID: 30766057 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
